Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-016094-16Phase 4Completed
Phase 4, single-arm trial of sevoflurane and remifentanil, sponsored by Ghent University Hospital. Primary endpoints: EEG depression in response to clinically relevant stimuli and Arousal reactions in response to clinically relevant stimuli. Started Oct 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-016094-16.